Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH8 DNAH9 DNAH7	6.94e-07	18	20	3	GO:0008569
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH8 DNAH9 DNAH7	2.77e-06	28	20	3	GO:0051959
GeneOntologyMolecularFunction	ryanodine-sensitive calcium-release channel activity	RYR1 RYR3	5.71e-06	4	20	2	GO:0005219
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH8 DNAH9 DNAH7	6.53e-06	37	20	3	GO:0045505
GeneOntologyMolecularFunction	calcium-induced calcium release activity	RYR1 RYR3	1.43e-05	6	20	2	GO:0048763
GeneOntologyMolecularFunction	microtubule motor activity	DNAH8 DNAH9 DNAH7	4.51e-05	70	20	3	GO:0003777
GeneOntologyMolecularFunction	intracellularly gated calcium channel activity	RYR1 RYR3	1.44e-04	18	20	2	GO:0015278
GeneOntologyMolecularFunction	cytoskeletal motor activity	DNAH8 DNAH9 DNAH7	2.13e-04	118	20	3	GO:0003774
GeneOntologyMolecularFunction	gated channel activity	KCNMA1 KCNV2 RYR1 RYR3	3.01e-04	334	20	4	GO:0022836
GeneOntologyMolecularFunction	NADPH binding	CBR3 NOS1	3.05e-04	26	20	2	GO:0070402
GeneOntologyMolecularFunction	monoatomic cation channel activity	KCNMA1 KCNV2 RYR1 RYR3	3.33e-04	343	20	4	GO:0005261
GeneOntologyMolecularFunction	ligand-gated monoatomic cation channel activity	KCNMA1 RYR1 RYR3	3.52e-04	140	20	3	GO:0099094
GeneOntologyMolecularFunction	ligand-gated calcium channel activity	RYR1 RYR3	4.36e-04	31	20	2	GO:0099604
GeneOntologyMolecularFunction	voltage-gated monoatomic cation channel activity	KCNMA1 KCNV2 RYR1	4.48e-04	152	20	3	GO:0022843
GeneOntologyMolecularFunction	intracellularly ligand-gated monoatomic ion channel activity	RYR1 RYR3	4.94e-04	33	20	2	GO:0005217
GeneOntologyMolecularFunction	voltage-gated monoatomic ion channel activity	KCNMA1 KCNV2 RYR1	7.57e-04	182	20	3	GO:0005244
GeneOntologyMolecularFunction	voltage-gated channel activity	KCNMA1 KCNV2 RYR1	7.82e-04	184	20	3	GO:0022832
GeneOntologyMolecularFunction	ligand-gated monoatomic ion channel activity	KCNMA1 RYR1 RYR3	8.98e-04	193	20	3	GO:0015276
GeneOntologyMolecularFunction	ligand-gated channel activity	KCNMA1 RYR1 RYR3	9.53e-04	197	20	3	GO:0022834
GeneOntologyMolecularFunction	monoatomic ion channel activity	KCNMA1 KCNV2 RYR1 RYR3	9.97e-04	459	20	4	GO:0005216
GeneOntologyMolecularFunction	metal ion transmembrane transporter activity	KCNMA1 KCNV2 RYR1 RYR3	1.05e-03	465	20	4	GO:0046873
GeneOntologyMolecularFunction	calmodulin binding	NOS1 RYR1 RYR3	1.49e-03	230	20	3	GO:0005516
GeneOntologyMolecularFunction	channel activity	KCNMA1 KCNV2 RYR1 RYR3	1.64e-03	525	20	4	GO:0015267
GeneOntologyMolecularFunction	passive transmembrane transporter activity	KCNMA1 KCNV2 RYR1 RYR3	1.65e-03	526	20	4	GO:0022803
GeneOntologyMolecularFunction	NADP binding	CBR3 NOS1	1.74e-03	62	20	2	GO:0050661
GeneOntologyMolecularFunction	inorganic cation transmembrane transporter activity	KCNMA1 KCNV2 RYR1 RYR3	3.12e-03	627	20	4	GO:0022890
GeneOntologyMolecularFunction	monoatomic cation transmembrane transporter activity	KCNMA1 KCNV2 RYR1 RYR3	3.84e-03	664	20	4	GO:0008324
GeneOntologyMolecularFunction	voltage-gated potassium channel activity	KCNMA1 KCNV2	4.62e-03	102	20	2	GO:0005249
GeneOntologyMolecularFunction	monooxygenase activity	CMAHP NOS1	5.84e-03	115	20	2	GO:0004497
GeneOntologyMolecularFunction	inorganic molecular entity transmembrane transporter activity	KCNMA1 KCNV2 RYR1 RYR3	6.14e-03	758	20	4	GO:0015318
GeneOntologyMolecularFunction	oxidoreductase activity	CMAHP CBR3 NOS1 PXDNL	6.37e-03	766	20	4	GO:0016491
GeneOntologyMolecularFunction	potassium channel activity	KCNMA1 KCNV2	7.18e-03	128	20	2	GO:0005267
GeneOntologyMolecularFunction	monoatomic ion transmembrane transporter activity	KCNMA1 KCNV2 RYR1 RYR3	7.19e-03	793	20	4	GO:0015075
GeneOntologyMolecularFunction	calcium channel activity	RYR1 RYR3	7.29e-03	129	20	2	GO:0005262
GeneOntologyMolecularFunction	ATP hydrolysis activity	DNAH8 DNAH9 DNAH7	9.22e-03	441	20	3	GO:0016887
GeneOntologyMolecularFunction	calcium ion transmembrane transporter activity	RYR1 RYR3	9.87e-03	151	20	2	GO:0015085
GeneOntologyMolecularFunction	heme binding	NOS1 PXDNL	1.03e-02	154	20	2	GO:0020037
GeneOntologyMolecularFunction	tetrapyrrole binding	NOS1 PXDNL	1.16e-02	164	20	2	GO:0046906
GeneOntologyMolecularFunction	potassium ion transmembrane transporter activity	KCNMA1 KCNV2	1.20e-02	167	20	2	GO:0015079
GeneOntologyMolecularFunction	transmembrane transporter binding	NOS1 CRBN	1.27e-02	172	20	2	GO:0044325
GeneOntologyMolecularFunction	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen	CMAHP NOS1	1.59e-02	194	20	2	GO:0016705
GeneOntologyMolecularFunction	ATP-dependent activity	DNAH8 DNAH9 DNAH7	2.23e-02	614	20	3	GO:0140657
GeneOntologyBiologicalProcess	muscle contraction	KCNMA1 TMOD4 NOS1 RYR1 RYR3	3.26e-05	400	20	5	GO:0006936
GeneOntologyBiologicalProcess	cellular response to caffeine	RYR1 RYR3	4.89e-05	11	20	2	GO:0071313
GeneOntologyBiologicalProcess	cellular response to purine-containing compound	RYR1 RYR3	8.07e-05	14	20	2	GO:0071415
GeneOntologyBiologicalProcess	potassium ion transport	KCNMA1 NOS1 KCNV2 CRBN	1.21e-04	272	20	4	GO:0006813
GeneOntologyBiologicalProcess	muscle system process	KCNMA1 TMOD4 NOS1 RYR1 RYR3	1.44e-04	547	20	5	GO:0003012
GeneOntologyBiologicalProcess	inorganic cation transmembrane transport	KCNMA1 NOS1 KCNV2 CRBN RYR1 RYR3	1.77e-04	922	20	6	GO:0098662
GeneOntologyBiologicalProcess	response to caffeine	RYR1 RYR3	1.86e-04	21	20	2	GO:0031000
GeneOntologyBiologicalProcess	cellular response to ATP	RYR1 RYR3	1.86e-04	21	20	2	GO:0071318
GeneOntologyBiologicalProcess	monoatomic cation transmembrane transport	KCNMA1 NOS1 KCNV2 CRBN RYR1 RYR3	1.99e-04	942	20	6	GO:0098655
GeneOntologyBiologicalProcess	response to alkaloid	NOS1 RYR1 RYR3	2.30e-04	125	20	3	GO:0043279
GeneOntologyBiologicalProcess	negative regulation of cytosolic calcium ion concentration	NOS1 RYR3	2.64e-04	25	20	2	GO:0051481
GeneOntologyBiologicalProcess	metal ion transport	KCNMA1 NOS1 KCNV2 CRBN RYR1 RYR3	2.76e-04	1000	20	6	GO:0030001
GeneOntologyBiologicalProcess	inorganic ion transmembrane transport	KCNMA1 NOS1 KCNV2 CRBN RYR1 RYR3	3.02e-04	1017	20	6	GO:0098660
GeneOntologyBiologicalProcess	release of sequestered calcium ion into cytosol	NOS1 RYR1 RYR3	3.63e-04	146	20	3	GO:0051209
GeneOntologyBiologicalProcess	negative regulation of sequestering of calcium ion	NOS1 RYR1 RYR3	3.70e-04	147	20	3	GO:0051283
GeneOntologyBiologicalProcess	regulation of sequestering of calcium ion	NOS1 RYR1 RYR3	3.85e-04	149	20	3	GO:0051282
GeneOntologyBiologicalProcess	sequestering of calcium ion	NOS1 RYR1 RYR3	4.16e-04	153	20	3	GO:0051208
GeneOntologyBiologicalProcess	response to calcium ion	KCNMA1 RYR1 RYR3	4.83e-04	161	20	3	GO:0051592
GeneOntologyBiologicalProcess	monoatomic ion transmembrane transport	KCNMA1 NOS1 KCNV2 CRBN RYR1 RYR3	4.95e-04	1115	20	6	GO:0034220
GeneOntologyBiologicalProcess	release of sequestered calcium ion into cytosol by sarcoplasmic reticulum	RYR1 RYR3	5.83e-04	37	20	2	GO:0014808
GeneOntologyBiologicalProcess	monoatomic cation transport	KCNMA1 NOS1 KCNV2 CRBN RYR1 RYR3	6.03e-04	1157	20	6	GO:0006812
GeneOntologyBiologicalProcess	release of sequestered calcium ion into cytosol by endoplasmic reticulum	RYR1 RYR3	6.48e-04	39	20	2	GO:1903514
GeneOntologyBiologicalProcess	response to ATP	RYR1 RYR3	6.82e-04	40	20	2	GO:0033198
GeneOntologyBiologicalProcess	cellular response to alkaloid	RYR1 RYR3	6.82e-04	40	20	2	GO:0071312
GeneOntologyBiologicalProcess	axonemal dynein complex assembly	DNAH8 DNAH7	7.16e-04	41	20	2	GO:0070286
GeneOntologyBiologicalProcess	sarcoplasmic reticulum calcium ion transport	RYR1 RYR3	8.25e-04	44	20	2	GO:0070296
GeneOntologyBiologicalProcess	negative regulation of potassium ion transport	NOS1 CRBN	9.01e-04	46	20	2	GO:0043267
GeneOntologyBiologicalProcess	action potential	KCNMA1 NOS1 KCNV2	9.20e-04	201	20	3	GO:0001508
GeneOntologyBiologicalProcess	regulation of muscle contraction	KCNMA1 NOS1 RYR1	9.33e-04	202	20	3	GO:0006937
GeneOntologyBiologicalProcess	cilium movement involved in cell motility	DNAH8 DNAH9 DNAH7	1.04e-03	210	20	3	GO:0060294
GeneOntologyBiologicalProcess	cilium-dependent cell motility	DNAH8 DNAH9 DNAH7	1.12e-03	215	20	3	GO:0060285
GeneOntologyBiologicalProcess	cilium or flagellum-dependent cell motility	DNAH8 DNAH9 DNAH7	1.12e-03	215	20	3	GO:0001539
GeneOntologyBiologicalProcess	striated muscle contraction	NOS1 RYR1 RYR3	1.15e-03	217	20	3	GO:0006941
GeneOntologyBiologicalProcess	calcium ion transmembrane import into cytosol	NOS1 RYR1 RYR3	1.15e-03	217	20	3	GO:0097553
GeneOntologyBiologicalProcess	protein homooligomerization	KCNV2 RYR1 RYR3	1.26e-03	224	20	3	GO:0051260
GeneOntologyBiologicalProcess	potassium ion transmembrane transport	KCNMA1 KCNV2 CRBN	1.39e-03	232	20	3	GO:0071805
GeneOntologyBiologicalProcess	monoatomic ion transport	KCNMA1 NOS1 KCNV2 CRBN RYR1 RYR3	1.49e-03	1374	20	6	GO:0006811
GeneOntologyBiologicalProcess	maintenance of location in cell	NOS1 RYR1 RYR3	1.90e-03	259	20	3	GO:0051651
GeneOntologyBiologicalProcess	cilium movement	DNAH8 DNAH9 DNAH7	1.95e-03	261	20	3	GO:0003341
GeneOntologyBiologicalProcess	calcium-mediated signaling	NOS1 RYR1 RYR3	2.06e-03	266	20	3	GO:0019722
GeneOntologyBiologicalProcess	vasodilation	KCNMA1 NOS1	2.19e-03	72	20	2	GO:0042311
GeneOntologyBiologicalProcess	protein homotetramerization	RYR1 RYR3	2.50e-03	77	20	2	GO:0051289
GeneOntologyBiologicalProcess	intracellular monoatomic cation homeostasis	KCNMA1 NOS1 RYR1 RYR3	2.53e-03	611	20	4	GO:0030003
GeneOntologyBiologicalProcess	intracellular monoatomic ion homeostasis	KCNMA1 NOS1 RYR1 RYR3	2.70e-03	622	20	4	GO:0006873
GeneOntologyBiologicalProcess	inorganic ion homeostasis	KCNMA1 NOS1 RYR1 RYR3	2.70e-03	622	20	4	GO:0098771
GeneOntologyBiologicalProcess	protein complex oligomerization	KCNV2 RYR1 RYR3	2.78e-03	296	20	3	GO:0051259
GeneOntologyBiologicalProcess	cellular response to calcium ion	RYR1 RYR3	3.25e-03	88	20	2	GO:0071277
GeneOntologyBiologicalProcess	regulation of muscle system process	KCNMA1 NOS1 RYR1	3.38e-03	317	20	3	GO:0090257
GeneOntologyBiologicalProcess	monoatomic cation homeostasis	KCNMA1 NOS1 RYR1 RYR3	4.24e-03	705	20	4	GO:0055080
GeneOntologyBiologicalProcess	response to estrogen	KCNMA1 NOS1	4.42e-03	103	20	2	GO:0043627
GeneOntologyBiologicalProcess	monoatomic ion homeostasis	KCNMA1 NOS1 RYR1 RYR3	4.50e-03	717	20	4	GO:0050801
GeneOntologyBiologicalProcess	intracellular calcium ion homeostasis	NOS1 RYR1 RYR3	4.78e-03	359	20	3	GO:0006874
GeneOntologyBiologicalProcess	axoneme assembly	DNAH8 DNAH7	4.94e-03	109	20	2	GO:0035082
GeneOntologyBiologicalProcess	response to osmotic stress	KCNMA1 RYR1	5.30e-03	113	20	2	GO:0006970
GeneOntologyBiologicalProcess	protein tetramerization	RYR1 RYR3	5.30e-03	113	20	2	GO:0051262
GeneOntologyBiologicalProcess	negative regulation of cation transmembrane transport	NOS1 CRBN	5.58e-03	116	20	2	GO:1904063
GeneOntologyBiologicalProcess	calcium ion homeostasis	NOS1 RYR1 RYR3	5.98e-03	389	20	3	GO:0055074
GeneOntologyBiologicalProcess	regulation of potassium ion transport	NOS1 CRBN	6.05e-03	121	20	2	GO:0043266
GeneOntologyBiologicalProcess	striated muscle cell differentiation	TMOD4 NOS1 RYR1	6.06e-03	391	20	3	GO:0051146
GeneOntologyBiologicalProcess	calcium ion transmembrane transport	NOS1 RYR1 RYR3	6.11e-03	392	20	3	GO:0070588
GeneOntologyBiologicalProcess	maintenance of location	NOS1 RYR1 RYR3	6.28e-03	396	20	3	GO:0051235
GeneOntologyBiologicalProcess	negative regulation of monoatomic ion transmembrane transport	NOS1 CRBN	6.35e-03	124	20	2	GO:0034766
GeneOntologyCellularComponent	axonemal dynein complex	DNAH8 DNAH9 DNAH7	1.70e-06	25	20	3	GO:0005858
GeneOntologyCellularComponent	sarcoplasm	KCNMA1 NOS1 RYR1 RYR3	3.80e-06	114	20	4	GO:0016528
GeneOntologyCellularComponent	sarcoplasmic reticulum membrane	NOS1 RYR1 RYR3	1.04e-05	45	20	3	GO:0033017
GeneOntologyCellularComponent	dynein complex	DNAH8 DNAH9 DNAH7	1.80e-05	54	20	3	GO:0030286
GeneOntologyCellularComponent	junctional membrane complex	RYR1 RYR3	3.12e-05	9	20	2	GO:0030314
GeneOntologyCellularComponent	outer dynein arm	DNAH8 DNAH9	5.71e-05	12	20	2	GO:0036157
GeneOntologyCellularComponent	cation channel complex	KCNMA1 KCNV2 RYR1 RYR3	6.55e-05	235	20	4	GO:0034703
GeneOntologyCellularComponent	supramolecular fiber	TMOD4 DNAH8 DNAH9 NOS1 DNAH7 RYR1 RYR3	7.22e-05	1179	20	7	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	TMOD4 DNAH8 DNAH9 NOS1 DNAH7 RYR1 RYR3	7.53e-05	1187	20	7	GO:0099081
GeneOntologyCellularComponent	sarcoplasmic reticulum	NOS1 RYR1 RYR3	7.80e-05	88	20	3	GO:0016529
GeneOntologyCellularComponent	sarcomere	TMOD4 NOS1 RYR1 RYR3	8.19e-05	249	20	4	GO:0030017
GeneOntologyCellularComponent	myofibril	TMOD4 NOS1 RYR1 RYR3	1.17e-04	273	20	4	GO:0030016
GeneOntologyCellularComponent	contractile muscle fiber	TMOD4 NOS1 RYR1 RYR3	1.48e-04	290	20	4	GO:0043292
GeneOntologyCellularComponent	Z disc	NOS1 RYR1 RYR3	3.85e-04	151	20	3	GO:0030018
GeneOntologyCellularComponent	monoatomic ion channel complex	KCNMA1 KCNV2 RYR1 RYR3	4.05e-04	378	20	4	GO:0034702
GeneOntologyCellularComponent	microtubule associated complex	DNAH8 DNAH9 DNAH7	4.64e-04	161	20	3	GO:0005875
GeneOntologyCellularComponent	I band	NOS1 RYR1 RYR3	5.08e-04	166	20	3	GO:0031674
GeneOntologyCellularComponent	sarcolemma	NOS1 RYR1 RYR3	7.52e-04	190	20	3	GO:0042383
GeneOntologyCellularComponent	smooth endoplasmic reticulum	RYR1 RYR3	8.78e-04	46	20	2	GO:0005790
GeneOntologyCellularComponent	axoneme	DNAH8 DNAH9 DNAH7	9.63e-04	207	20	3	GO:0005930
GeneOntologyCellularComponent	ciliary plasm	DNAH8 DNAH9 DNAH7	9.77e-04	208	20	3	GO:0097014
GeneOntologyCellularComponent	transmembrane transporter complex	KCNMA1 KCNV2 RYR1 RYR3	1.36e-03	523	20	4	GO:1902495
GeneOntologyCellularComponent	9+2 motile cilium	DNAH8 DNAH9 DNAH7	1.44e-03	238	20	3	GO:0097729
GeneOntologyCellularComponent	perinuclear region of cytoplasm	KCNMA1 NOS1 CRBN RYR1 RYR3	1.56e-03	934	20	5	GO:0048471
GeneOntologyCellularComponent	transporter complex	KCNMA1 KCNV2 RYR1 RYR3	1.64e-03	550	20	4	GO:1990351
GeneOntologyCellularComponent	calcium channel complex	RYR1 RYR3	2.19e-03	73	20	2	GO:0034704
GeneOntologyCellularComponent	T-tubule	NOS1 RYR1	2.56e-03	79	20	2	GO:0030315
GeneOntologyCellularComponent	plasma membrane bounded cell projection cytoplasm	DNAH8 DNAH9 DNAH7	3.25e-03	317	20	3	GO:0032838
GeneOntologyCellularComponent	voltage-gated potassium channel complex	KCNMA1 KCNV2	3.38e-03	91	20	2	GO:0008076
GeneOntologyCellularComponent	potassium channel complex	KCNMA1 KCNV2	4.39e-03	104	20	2	GO:0034705
GeneOntologyCellularComponent	motile cilium	DNAH8 DNAH9 DNAH7	4.47e-03	355	20	3	GO:0031514
GeneOntologyCellularComponent	cytoplasmic region	DNAH8 DNAH9 DNAH7	4.65e-03	360	20	3	GO:0099568
GeneOntologyCellularComponent	caveola	KCNMA1 NOS1	4.99e-03	111	20	2	GO:0005901
GeneOntologyCellularComponent	plasma membrane raft	KCNMA1 NOS1	8.59e-03	147	20	2	GO:0044853
GeneOntologyCellularComponent	azurophil granule	NOS1 FUCA2	1.01e-02	160	20	2	GO:0042582
GeneOntologyCellularComponent	primary lysosome	NOS1 FUCA2	1.01e-02	160	20	2	GO:0005766
GeneOntologyCellularComponent	membrane protein complex	KCNMA1 KCNV2 LRRN3 RYR1 RYR3	1.17e-02	1498	20	5	GO:0098796
GeneOntologyCellularComponent	cytoplasmic side of plasma membrane	RYR1 RYR3	1.33e-02	185	20	2	GO:0009898
GeneOntologyCellularComponent	microtubule	DNAH8 DNAH9 DNAH7	1.36e-02	533	20	3	GO:0005874
GeneOntologyCellularComponent	axon terminus	KCNMA1 NOS1	1.69e-02	210	20	2	GO:0043679
MousePheno	abnormal muscle relaxation	KCNMA1 NOS1 RYR1	5.15e-05	61	17	3	MP:0004036
Domain	Dynein_heavy_dom-2	DNAH8 DNAH9 DNAH7	3.23e-07	14	19	3	IPR013602
Domain	Dynein_heavy_chain_D4_dom	DNAH8 DNAH9 DNAH7	3.23e-07	14	19	3	IPR024317
Domain	DHC_N2	DNAH8 DNAH9 DNAH7	3.23e-07	14	19	3	PF08393
Domain	MT	DNAH8 DNAH9 DNAH7	3.23e-07	14	19	3	PF12777
Domain	AAA_8	DNAH8 DNAH9 DNAH7	3.23e-07	14	19	3	PF12780
Domain	Dynein_HC_stalk	DNAH8 DNAH9 DNAH7	3.23e-07	14	19	3	IPR024743
Domain	DHC_fam	DNAH8 DNAH9 DNAH7	4.03e-07	15	19	3	IPR026983
Domain	Dynein_heavy_dom	DNAH8 DNAH9 DNAH7	4.03e-07	15	19	3	IPR004273
Domain	Dynein_heavy	DNAH8 DNAH9 DNAH7	4.03e-07	15	19	3	PF03028
Domain	RR_TM4-6	RYR1 RYR3	2.94e-06	3	19	2	PF06459
Domain	Ryanrecept_TM4-6	RYR1 RYR3	2.94e-06	3	19	2	IPR009460
Domain	RyR	RYR1 RYR3	2.94e-06	3	19	2	PF02026
Domain	Ryanodine_rcpt	RYR1 RYR3	2.94e-06	3	19	2	IPR003032
Domain	Ryan_recept	RYR1 RYR3	2.94e-06	3	19	2	IPR013333
Domain	Ion_trans_dom	KCNMA1 KCNV2 RYR1 RYR3	4.75e-06	114	19	4	IPR005821
Domain	Ion_trans	KCNMA1 KCNV2 RYR1 RYR3	4.75e-06	114	19	4	PF00520
Domain	RIH_assoc	RYR1 RYR3	1.47e-05	6	19	2	PF08454
Domain	RIH_assoc-dom	RYR1 RYR3	1.47e-05	6	19	2	IPR013662
Domain	Ins145_P3_rec	RYR1 RYR3	1.47e-05	6	19	2	PF08709
Domain	RYDR_ITPR	RYR1 RYR3	1.47e-05	6	19	2	PF01365
Domain	RIH_dom	RYR1 RYR3	1.47e-05	6	19	2	IPR000699
Domain	Ins145_P3_rcpt	RYR1 RYR3	1.47e-05	6	19	2	IPR014821
Domain	Ryanodine_recept-rel	RYR1 RYR3	1.47e-05	6	19	2	IPR015925
Domain	-	RYR1 RYR3	1.47e-05	6	19	2	1.25.10.30
Domain	Dynein_heavy_dom-1	DNAH8 DNAH9	2.74e-05	8	19	2	IPR013594
Domain	DHC_N1	DNAH8 DNAH9	2.74e-05	8	19	2	PF08385
Domain	MIR	RYR1 RYR3	4.39e-05	10	19	2	PS50919
Domain	MIR	RYR1 RYR3	4.39e-05	10	19	2	PF02815
Domain	MIR	RYR1 RYR3	4.39e-05	10	19	2	SM00472
Domain	MIR_motif	RYR1 RYR3	4.39e-05	10	19	2	IPR016093
Domain	ATPase_dyneun-rel_AAA	DNAH8 DNAH9	8.86e-05	14	19	2	IPR011704
Domain	AAA_5	DNAH8 DNAH9	8.86e-05	14	19	2	PF07728
Domain	SPRY	TRIM43B RYR1 RYR3	8.96e-05	87	19	3	SM00449
Domain	SPRY	TRIM43B RYR1 RYR3	1.13e-04	94	19	3	PF00622
Domain	SPRY_dom	TRIM43B RYR1 RYR3	1.13e-04	94	19	3	IPR003877
Domain	B30.2/SPRY	TRIM43B RYR1 RYR3	1.16e-04	95	19	3	IPR001870
Domain	B302_SPRY	TRIM43B RYR1 RYR3	1.16e-04	95	19	3	PS50188
Domain	AAA+_ATPase	DNAH8 DNAH9 DNAH7	3.97e-04	144	19	3	IPR003593
Domain	AAA	DNAH8 DNAH9 DNAH7	3.97e-04	144	19	3	SM00382
Domain	VG_K_chnl	KCNMA1 KCNV2	5.08e-04	33	19	2	IPR028325
Domain	ConA-like_dom	TRIM43B RYR1 RYR3	1.34e-03	219	19	3	IPR013320
Domain	EF_hand_dom	DNAH7 RYR1 RYR3	1.58e-03	232	19	3	IPR002048
Domain	Cys-rich_flank_reg_C	PXDNL LRRN3	3.72e-03	90	19	2	IPR000483
Domain	LRRCT	PXDNL LRRN3	3.72e-03	90	19	2	SM00082
Domain	-	TMOD4 PXDNL LRRN3	3.97e-03	321	19	3	3.80.10.10
Domain	L_dom-like	TMOD4 PXDNL LRRN3	4.22e-03	328	19	3	IPR032675
Domain	LRRNT	PXDNL LRRN3	4.40e-03	98	19	2	IPR000372
Domain	LRRNT	PXDNL LRRN3	4.40e-03	98	19	2	SM00013
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT	DNAH8 DNAH9 DNAH7	2.25e-06	27	14	3	M47755
Pathway	KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT	DNAH8 DNAH9 DNAH7	9.40e-06	43	14	3	M47669
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT	DNAH8 DNAH9 DNAH7	1.08e-05	45	14	3	M47670
Pathway	WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS	NOS1 RYR1 GPR182 RYR3	1.26e-05	154	14	4	MM15974
Pathway	WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS	NOS1 RYR1 GPR182 RYR3	1.32e-05	156	14	4	M39475
Pathway	REACTOME_MUSCLE_CONTRACTION	TMOD4 NOS1 RYR1 RYR3	1.65e-05	165	14	4	MM15026
Pathway	REACTOME_ION_HOMEOSTASIS	NOS1 RYR1 RYR3	1.88e-05	54	14	3	M27460
Pathway	REACTOME_ION_HOMEOSTASIS	NOS1 RYR1 RYR3	1.88e-05	54	14	3	MM15202
Pathway	REACTOME_MUSCLE_CONTRACTION	TMOD4 NOS1 RYR1 RYR3	3.73e-05	203	14	4	M5485
Pathway	KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY	RYR1 RYR3	5.01e-05	11	14	2	M47958
Pathway	WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING	RYR1 RYR3	7.10e-05	13	14	2	M39589
Pathway	REACTOME_CARDIAC_CONDUCTION	NOS1 RYR1 RYR3	1.30e-04	103	14	3	MM15196
Pathway	KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY	RYR1 RYR3	1.55e-04	19	14	2	M47760
Pathway	REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE	KCNMA1 NOS1	2.09e-04	22	14	2	M915
Pathway	REACTOME_CARDIAC_CONDUCTION	NOS1 RYR1 RYR3	2.59e-04	130	14	3	M27454
Pathway	KEGG_CALCIUM_SIGNALING_PATHWAY	NOS1 RYR1 RYR3	6.50e-04	178	14	3	M2890
Pathway	KEGG_LONG_TERM_DEPRESSION	NOS1 RYR1	2.13e-03	70	14	2	M8232
Pathway	WP_ALZHEIMERS_DISEASE	NOS1 RYR3	2.37e-03	74	14	2	MM15962
Pathway	REACTOME_PLATELET_HOMEOSTASIS	KCNMA1 NOS1	3.19e-03	86	14	2	M916
Pathway	REACTOME_STIMULI_SENSING_CHANNELS	RYR1 RYR3	4.21e-03	99	14	2	MM14910
Pathway	REACTOME_POTASSIUM_CHANNELS	KCNMA1 KCNV2	4.54e-03	103	14	2	M1073
Pathway	REACTOME_STIMULI_SENSING_CHANNELS	RYR1 RYR3	4.81e-03	106	14	2	M27200
Pathway	WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS	RYR1 RYR3	9.05e-03	147	14	2	MM15854
Pathway	WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS	RYR1 RYR3	9.53e-03	151	14	2	M39329
Pathway	KEGG_ALZHEIMERS_DISEASE	NOS1 RYR3	1.14e-02	166	14	2	M16024
Pathway	REACTOME_ION_CHANNEL_TRANSPORT	RYR1 RYR3	1.28e-02	176	14	2	MM15718
Pathway	REACTOME_ION_CHANNEL_TRANSPORT	RYR1 RYR3	1.38e-02	183	14	2	M997
Pubmed	Principal mutation hotspot for central core disease and related myopathies in the C-terminal transmembrane region of the RYR1 gene.	RYR1 RYR3	3.14e-07	2	20	2	12565913
Pubmed	Contractile impairment and structural alterations of skeletal muscles from knockout mice lacking type 1 and type 3 ryanodine receptors.	RYR1 RYR3	3.14e-07	2	20	2	9489997
Pubmed	Voltage-dependent Ca2+ channels, not ryanodine receptors, activate Ca2+-dependent BK potassium channels in human retinal pigment epithelial cells.	KCNMA1 RYR1	3.14e-07	2	20	2	19096717
Pubmed	Temporal and spatial mouse brain expression of cereblon, an ionic channel regulator involved in human intelligence.	KCNMA1 CRBN	3.14e-07	2	20	2	20131966
Pubmed	Ryanodine receptors in muscarinic receptor-mediated bronchoconstriction.	RYR1 RYR3	3.14e-07	2	20	2	15894801
Pubmed	Functional and morphological features of skeletal muscle from mutant mice lacking both type 1 and type 3 ryanodine receptors.	RYR1 RYR3	3.14e-07	2	20	2	9192302
Pubmed	The block of ryanodine receptors selectively inhibits fetal myoblast differentiation.	RYR1 RYR3	3.14e-07	2	20	2	12640042
Pubmed	Isolation and partial cloning of ryanodine-sensitive Ca2+ release channel protein isoforms from human myometrial smooth muscle.	RYR1 RYR3	3.14e-07	2	20	2	7556644
Pubmed	Possible involvement of ryanodine receptor-mediated intracellular calcium release in the effect of corticotropin-releasing factor on adrenocorticotropin secretion.	RYR1 RYR3	3.14e-07	2	20	2	14592949
Pubmed	Variable phenotype of del45-55 Becker patients correlated with nNOSμ mislocalization and RYR1 hypernitrosylation.	NOS1 RYR1	3.14e-07	2	20	2	22589245
Pubmed	Morphological abnormalities of adrenal gland and hypertrophy of liver in mutant mice lacking ryanodine receptors.	RYR1 RYR3	3.14e-07	2	20	2	9799464
Pubmed	Dysregulation of large-conductance Ca2+-activated K+ channel expression in nonsyndromal mental retardation due to a cereblon p.R419X mutation.	KCNMA1 CRBN	3.14e-07	2	20	2	18414909
Pubmed	Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development.	RYR1 RYR3	3.14e-07	2	20	2	17118445
Pubmed	Effect of calmodulin on Ca2+-induced Ca2+ release of skeletal muscle from mutant mice expressing either ryanodine receptor type 1 or type 3.	RYR1 RYR3	3.14e-07	2	20	2	9817784
Pubmed	RyR3 amplifies RyR1-mediated Ca(2+)-induced Ca(2+) release in neonatal mammalian skeletal muscle.	RYR1 RYR3	3.14e-07	2	20	2	11500519
Pubmed	Calcineurin upregulates local Ca(2+) signaling through ryanodine receptor-1 in airway smooth muscle cells.	RYR1 RYR3	9.42e-07	3	20	2	25239916
Pubmed	Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor.	RYR1 RYR3	9.42e-07	3	20	2	7621815
Pubmed	SPRY domains in ryanodine receptors (Ca(2+)-release channels).	RYR1 RYR3	9.42e-07	3	20	2	9204703
Pubmed	A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice.	RYR1 RYR3	9.42e-07	3	20	2	18643873
Pubmed	Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2).	RYR1 RYR3	9.42e-07	3	20	2	11159936
Pubmed	The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues.	RYR1 RYR3	9.42e-07	3	20	2	7876312
Pubmed	Expression of the ryanodine receptor type 3 calcium release channel during development and differentiation of mammalian skeletal muscle cells.	RYR1 RYR3	9.42e-07	3	20	2	9242641
Pubmed	Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: an antisense study.	RYR1 RYR3	9.42e-07	3	20	2	18403125
Pubmed	Characterization and mapping of the 12 kDa FK506-binding protein (FKBP12)-binding site on different isoforms of the ryanodine receptor and of the inositol 1,4,5-trisphosphate receptor.	RYR1 RYR3	9.42e-07	3	20	2	11171121
Pubmed	Ryanodine receptors are expressed in epidermal keratinocytes and associated with keratinocyte differentiation and epidermal permeability barrier homeostasis.	RYR1 RYR3	9.42e-07	3	20	2	21881589
Pubmed	Differential alterations in expressions of ryanodine receptor subtypes in cerebellar cortical neurons of an ataxic mutant, rolling mouse Nagoya.	RYR1 RYR3	9.42e-07	3	20	2	18313230
Pubmed	Bidirectional coupling between ryanodine receptors and Ca2+ release-activated Ca2+ (CRAC) channel machinery sustains store-operated Ca2+ entry in human T lymphocytes.	RYR1 RYR3	9.42e-07	3	20	2	22948152
Pubmed	Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain.	RYR1 RYR3	9.42e-07	3	20	2	10788707
Pubmed	Heterogeneous gene expression and functional activity of ryanodine receptors in resistance and conduit pulmonary as well as mesenteric artery smooth muscle cells.	RYR1 RYR3	9.42e-07	3	20	2	18434746
Pubmed	Molecular identification of the ryanodine receptor pore-forming segment.	RYR1 RYR3	9.42e-07	3	20	2	10473538
Pubmed	Chromosomal localization of murine ryanodine receptor genes RYR1, RYR2, and RYR3 by in situ hybridization.	RYR1 RYR3	9.42e-07	3	20	2	7959768
Pubmed	Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors).	RYR1 RYR3	9.42e-07	3	20	2	12213830
Pubmed	The organization of proteins in the human red blood cell membrane. A review.	RYR1 RYR3	9.42e-07	3	20	2	4600883
Pubmed	Regulation of mouse egg activation: presence of ryanodine receptors and effects of microinjected ryanodine and cyclic ADP ribose on uninseminated and inseminated eggs.	RYR1 RYR3	9.42e-07	3	20	2	7635066
Pubmed	Characterization of the binding sites for the interactions between FKBP12 and intracellular calcium release channels.	RYR1 RYR3	1.88e-06	4	20	2	22100703
Pubmed	Requirement for the ryanodine receptor type 3 for efficient contraction in neonatal skeletal muscles.	RYR1 RYR3	1.88e-06	4	20	2	9384575
Pubmed	A glutathione deficit alters dopamine modulation of L-type calcium channels via D2 and ryanodine receptors in neurons.	RYR1 RYR3	1.88e-06	4	20	2	18206662
Pubmed	Partial cloning and differential expression of ryanodine receptor/calcium-release channel genes in human tissues including the hippocampus and cerebellum.	RYR1 RYR3	1.88e-06	4	20	2	9607712
Pubmed	Conserved and divergent functions of Nfix in skeletal muscle development during vertebrate evolution.	RYR1 RYR3	1.88e-06	4	20	2	23482488
Pubmed	iNOS is not responsible for RyR1 S-nitrosylation in mdx mice with truncated dystrophin.	NOS1 RYR1	1.88e-06	4	20	2	32693782
Pubmed	Ryanodine receptor calcium release channels: lessons from structure-function studies.	RYR1 RYR3	1.88e-06	4	20	2	23413940
Pubmed	Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells.	RYR1 RYR3	3.14e-06	5	20	2	19011160
Pubmed	Presenilins regulate calcium homeostasis and presynaptic function via ryanodine receptors in hippocampal neurons.	RYR1 RYR3	3.14e-06	5	20	2	23918386
Pubmed	Membrane depolarization causes a direct activation of G protein-coupled receptors leading to local Ca2+ release in smooth muscle.	RYR1 RYR3	4.71e-06	6	20	2	19549818
Pubmed	HIV-1 Tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mitochondrial hyperpolarization.	RYR1 RYR3	4.71e-06	6	20	2	19009018
Pubmed	Type 3 and type 1 ryanodine receptors are localized in triads of the same mammalian skeletal muscle fibers.	RYR1 RYR3	4.71e-06	6	20	2	10444070
Pubmed	IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1.	RYR1 RYR3	4.71e-06	6	20	2	16844763
Pubmed	Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos.	RYR1 RYR3	4.71e-06	6	20	2	26025922
Pubmed	FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells.	RYR1 RYR3	4.71e-06	6	20	2	14592808
Pubmed	Roles of I(f) and intracellular Ca2+ release in spontaneous activity of ventricular cardiomyocytes during murine embryonic development.	RYR1 RYR3	4.71e-06	6	20	2	23463619
Pubmed	A calcium-induced calcium release mechanism supports luteinizing hormone-induced testosterone secretion in mouse Leydig cells.	RYR1 RYR3	4.71e-06	6	20	2	20519450
Pubmed	Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging.	RYR1 RYR3	4.71e-06	6	20	2	25966694
Pubmed	CRL4 antagonizes SCFFbxo7-mediated turnover of cereblon and BK channel to regulate learning and memory.	KCNMA1 CRBN	4.71e-06	6	20	2	29370161
Pubmed	Genesis of muscle fiber-type diversity during mouse embryogenesis relies on Six1 and Six4 gene expression.	TMOD4 NOS1 CPT1B	4.92e-06	58	20	3	21884692
Pubmed	Mutations in DNAH17, Encoding a Sperm-Specific Axonemal Outer Dynein Arm Heavy Chain, Cause Isolated Male Infertility Due to Asthenozoospermia.	DNAH8 DNAH9	6.59e-06	7	20	2	31178125
Pubmed	Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax.	RYR1 RYR3	6.59e-06	7	20	2	20962236
Pubmed	Developmental expression of the calcium release channels during early neurogenesis of the mouse cerebral cortex.	RYR1 RYR3	6.59e-06	7	20	2	11860456
Pubmed	ORAI1, STIM1/2, and RYR1 shape subsecond Ca2+ microdomains upon T cell activation.	RYR1 RYR3	8.78e-06	8	20	2	30563862
Pubmed	Sequential docking, molecular differentiation, and positioning of T-Tubule/SR junctions in developing mouse skeletal muscle.	RYR1 RYR3	8.78e-06	8	20	2	11784029
Pubmed	Neuromuscular synaptic patterning requires the function of skeletal muscle dihydropyridine receptors.	RYR1 RYR3	8.78e-06	8	20	2	21441923
Pubmed	Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death.	RYR1 RYR3	8.78e-06	8	20	2	19033399
Pubmed	Increased muscle stress-sensitivity induced by selenoprotein N inactivation in mouse: a mammalian model for SEPN1-related myopathy.	RYR1 RYR3	1.13e-05	9	20	2	21858002
Pubmed	Pih1d3 is required for cytoplasmic preassembly of axonemal dynein in mouse sperm.	DNAH9 DNAH7	1.72e-05	11	20	2	24421334
Pubmed	New molecular components supporting ryanodine receptor-mediated Ca(2+) release: roles of junctophilin and TRIC channel in embryonic cardiomyocytes.	RYR1 RYR3	2.07e-05	12	20	2	19095005
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH8 DNAH7	2.85e-05	14	20	2	9373155
Pubmed	L-type voltage-dependent calcium channel alpha subunit 1C is a novel candidate gene associated with secondary hyperparathyroidism: an application of haplotype-based analysis for multiple linked single nucleotide polymorphisms.	KCNMA1 RYR1 RYR3	7.37e-05	143	20	3	20424473
Pubmed	Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.	RYR1 RHBDL2	1.35e-04	30	20	2	20080650
Pubmed	Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development.	RYR1 RYR3	2.18e-04	38	20	2	30786075
Pubmed	Multiple mouse chromosomal loci for dynein-based motility.	DNAH8 DNAH9	3.34e-04	47	20	2	8812413
GeneFamily	Dyneins, axonemal	DNAH8 DNAH9 DNAH7	3.12e-07	17	15	3	536
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR1 RYR3	1.93e-06	3	15	2	287
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	PXDNL LRRN3	7.67e-03	161	15	2	593
GeneFamily	EF-hand domain containing	DNAH7 RYR3	1.38e-02	219	15	2	863
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNMA1 DNAH9 KCNV2 RYR3	7.14e-07	160	20	4	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNMA1 DNAH9 KCNV2 RYR3	7.14e-07	160	20	4	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Ptgfr\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	DNAH9 RYR1 RYR3	2.42e-05	127	20	3	fb58f4b4d3722f4b9a2e4946c0244c5b70dd883b
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_ALM_Sla\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CBR3 NOS1 RYR1	2.71e-05	132	20	3	ddebc0b233fdbb73ceb70187945bbed8fd273f2a
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chodl\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TMOD4 DNAH9 NOS1	3.03e-05	137	20	3	5cb84392e4483f50e09fb7395e2ec98f3eb6ecf3
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	DNAH9 RYR1 RYR3	3.52e-05	144	20	3	08005be9e3367f78ef27e125d9cce5ca53f4bd2d
ToppCell	COVID-19-kidney-Technical/muscle\|kidney / Disease (COVID-19 only), tissue and cell type	DNAH8 DNAH9 NOS1	3.82e-05	148	20	3	0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e
ToppCell	368C-Fibroblasts-Fibroblast-F\|368C / Donor, Lineage, Cell class and subclass (all cells)	CBR3 DNAH7 PXDNL	4.55e-05	157	20	3	74038192f016f95f80e0189035ee8ccc22ceb1b8
ToppCell	368C-Fibroblasts-Fibroblast-F-\|368C / Donor, Lineage, Cell class and subclass (all cells)	CBR3 DNAH7 PXDNL	4.55e-05	157	20	3	982e6ea78c7dabdb7c07c4a5fb2425d5e45b5b94
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRIM43B LRRN3 RYR3	4.72e-05	159	20	3	4000ed0d3b7d488722bcd0042fa2ff4405aaab82
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	DNAH8 DNAH9 RYR1	4.72e-05	159	20	3	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRIM43B LRRN3 RYR3	4.72e-05	159	20	3	7619d0d49738dd08daf01b42664691a5323aa793
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	KCNMA1 RYR3 CPT1B	5.09e-05	163	20	3	1e8730d75cccf7292010683ab4e81a69d8e3bfa9
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TRIM43B LRRN3 RYR3	5.37e-05	166	20	3	5e3b998d740b24f790fad37350d704ca0ea10b77
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TRIM43B LRRN3 RYR3	5.37e-05	166	20	3	bcdaab49bde5beba750b76fdcc3781a3c12c4fff
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CMAHP RYR3 CPT1B	5.66e-05	169	20	3	d18b823836ca6fba79a2d2f10cb9966fa2623af2
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CMAHP RYR3 CPT1B	5.66e-05	169	20	3	befb9b1618ea30fbf8983bcc493853da53b809c3
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMOD4 DNAH9 RYR3	5.66e-05	169	20	3	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	NS-moderate-d_07-13-Epithelial-Ionocyte\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	KCNMA1 CBR3 RAI2	6.50e-05	177	20	3	99500aed584f793aaf308f8afbf5d1c6a9b4ee55
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH9 DNAH7 CPT1B	6.61e-05	178	20	3	3b12db04006db6e94fc45649a4b3a63b92f21a61
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	KCNMA1 PXDNL RYR3	8.02e-05	190	20	3	938d1f66094b1c94606e0d40213a39e5112f3322
ToppCell	Control-Epithelial\|Control / Condition, Lineage and Cell class	DNAH9 DNAH7 RYR3	8.14e-05	191	20	3	6228302febdb3dffe37dece7062d27ac9ccc6d4b
ToppCell	Control-Epithelial-Ciliated_cells\|Control / Condition, Lineage and Cell class	DNAH9 DNAH7 RYR3	8.14e-05	191	20	3	ea1d2c6838119b7019e9a2ff71d6212262b51b57
ToppCell	droplet-Heart-nan-18m-Endothelial-endocardial_endothelial_cells\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRIM43B GPR182 RAI2	8.27e-05	192	20	3	0b9b2eaed45456d7d74ce78a64ef4a26ac2458fb
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	DNAH9 NOS1 RYR3	8.66e-05	195	20	3	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	DNAH9 NOS1 RYR3	8.66e-05	195	20	3	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	Fibroblasts-DKK3+_Fibroblasts\|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	KCNMA1 PXDNL LRRN3	8.79e-05	196	20	3	24d64b67aa9b0e8215ad06f9101c1314b3483620
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	CMAHP DNAH9 DNAH7	8.79e-05	196	20	3	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	CMAHP DNAH9 DNAH7	8.79e-05	196	20	3	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	Transverse-(5)_Dendritic_cell-(53)_Lymphoid_DC\|Transverse / shred on region, Cell_type, and subtype	KCNMA1 NOS1 RYR1	8.92e-05	197	20	3	15b87fd3906d7388c271d30d0c64b1bcc490801c
ToppCell	Transverse-Dendritic_cell-Lymphoid_DC\|Transverse / Region, Cell class and subclass	KCNMA1 NOS1 RYR1	8.92e-05	197	20	3	a58af0ea82f76f2a7abac1f62629ff20d552fc63
ToppCell	Bronchus_Control_(B.)-Epithelial-TX-Transitional_AT2\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	KCNMA1 TMOD4 RHBDL2	9.19e-05	199	20	3	cd581d7330b471431ef427f8a4f5be553f70e068
ToppCell	Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Chodl_(Low-threshold_spiking_interneuron,_Npy+/Sst+)--\|Striatum / BrainAtlas - Mouse McCarroll V32	TMOD4 NOS1	5.38e-04	77	20	2	7bb18406d404c51ee938cc577c155dc51868ddb9
ToppCell	Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Chodl_(Low-threshold_spiking_interneuron,_Npy+/Sst+)\|Striatum / BrainAtlas - Mouse McCarroll V32	TMOD4 NOS1	5.38e-04	77	20	2	ac311740424ff75b478b3c19fa0fae93776eb54e
ToppCell	Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Chodl_(Low-threshold_spiking_interneuron,_Npy+/Sst+)-\|Striatum / BrainAtlas - Mouse McCarroll V32	TMOD4 NOS1	5.38e-04	77	20	2	9f2dbf922acb905d636427a766a217c0db9671d2
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Chodl_(MGE-derived_cortical_interneurons--Long-range-projecting_interneurons)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	DNAH9 NOS1	5.81e-04	80	20	2	1f022bd04de842ec7193e98acae0df17913f4749
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Chodl_(MGE-derived_cortical_interneurons--Long-range-projecting_interneurons)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	DNAH9 NOS1	5.81e-04	80	20	2	f102890f86fffb30d180a2450b71581181c803cf
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Npsr1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	DNAH9 RYR1	5.96e-04	81	20	2	5d9b08bc1ae6ecb894c88c9784fdc4203682d087
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_and_Lobular_Carcinoma-5\|TCGA-Breast / Sample_Type by Project: Shred V9	RYR1 FUCA2	9.23e-04	101	20	2	f4db710b2510cdbee26dd5c3b581c85fe6f0be00
ToppCell	COVID-19-Heart-Fib_+_CM\|Heart / Disease (COVID-19 only), tissue and cell type	NOS1 RYR1	9.79e-04	104	20	2	0b60a56a46f1fe3f8224ec6399d009a34a117a21
ToppCell	Thalamus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)\|Thalamus / BrainAtlas - Mouse McCarroll V32	CMAHP CPT1B	1.11e-03	111	20	2	567e5ac2c78d45db207067f0f152bb24ed048c50
ToppCell	Thalamus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-\|Thalamus / BrainAtlas - Mouse McCarroll V32	CMAHP CPT1B	1.11e-03	111	20	2	d1ec8e8e9adb11511b4ef363cc6f99286e2cc842
ToppCell	Thalamus-Hematopoietic-MACROPHAGE-MP1(C1qb)\|Thalamus / BrainAtlas - Mouse McCarroll V32	CMAHP CPT1B	1.11e-03	111	20	2	fd7aa25e83a0d762969e3966a658652da40c490e
ToppCell	Thalamus-Hematopoietic-MACROPHAGE\|Thalamus / BrainAtlas - Mouse McCarroll V32	CMAHP CPT1B	1.11e-03	111	20	2	d48561078c387ac856c1c30e3d7a3e75ebde942e
ToppCell	Thalamus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--\|Thalamus / BrainAtlas - Mouse McCarroll V32	CMAHP CPT1B	1.11e-03	111	20	2	a1b7940c6fa0e5a58aa4798b604469d79f33fa44
ToppCell	(05)_Ciliated-(3)_72hpi\|(05)_Ciliated / shred by cell type and Timepoint	DNAH8 CPT1B	1.15e-03	113	20	2	eaa5bc8f8183b353ee1e7618e99220eb3684cd60
ToppCell	Control-B_memory-6\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	KCNMA1 DNAH8	1.39e-03	124	20	2	3e987915026f503e8d072a837b6e7a34252e5c63
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Hpgd\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	RYR1 RYR3	1.43e-03	126	20	2	9b04ca8a46cc30119baf6ef27711a0b2a6b4a0c9
ToppCell	URO-Lymphocyte-T_NK-CD8_Naive\|URO / Disease, Lineage and Cell Type	NOS1 LRRN3	1.62e-03	134	20	2	142b7db0c2b686c8f2704ff7bcd9b44dfcb07403
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-9\|TCGA-Brain / Sample_Type by Project: Shred V9	DNAH7 RYR1	1.62e-03	134	20	2	2647453f44b0e0a8f27ef9bba750e99eb40efc8b
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	RYR1 RYR3	1.62e-03	134	20	2	cb676d5bbc468bd3ce1b6712d41c986ee9221ac5
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Agt_(Agt)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CMAHP GPR182	1.64e-03	135	20	2	4cb399620aa9edc2ca59e4df76ab7011ceb58db9
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_2\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CMAHP GPR182	1.64e-03	135	20	2	6bd2a0bfd8d20950f1b66810668682dc055a0ada
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CMAHP GPR182	1.64e-03	135	20	2	7e3559ed0fef7916d1938b4e1a9fa4456a60e3d3
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Agt_(Agt)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CMAHP GPR182	1.64e-03	135	20	2	97989546826bf3739e1b86a10832a457fd37c5d2
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-7\|TCGA-Stomach / Sample_Type by Project: Shred V9	KCNMA1 RYR3	1.64e-03	135	20	2	451e90c154e26ae4f72269d6765e7ef51d67313a
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Cdh13\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	RYR1 RYR3	1.66e-03	136	20	2	1f3000d5f105c87c80f8ae1dd2264bcd7f757a9c
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast-matrix_-_mature_3\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	TMOD4 LRRN3	1.69e-03	137	20	2	9bfdbc102cdd861996b3c4eac35b606be8af97eb
ToppCell	COVID-19-kidney-Technical/muscle\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DNAH8 NOS1	1.74e-03	139	20	2	13247bcb21c57c808657e0f543d6f134eeea7cc1
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DNAH8 CPT1B	1.76e-03	140	20	2	af9efcbaeeae69fcdac4a15fa244728b65915564
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	RYR1 RYR3	1.76e-03	140	20	2	7cc891d676555609add6fc7880735d948a2ad801
ToppCell	TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue-2\|TCGA-Bladder / Sample_Type by Project: Shred V9	KCNMA1 RYR3	1.79e-03	141	20	2	1baa054c2ae3b446d1954244b7fbf8af824ef345
ToppCell	facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNMA1 DNAH9	1.79e-03	141	20	2	4aa4b3476dc5abefbd348353cfe711cd5fe3d52f
ToppCell	facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNMA1 DNAH9	1.79e-03	141	20	2	e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8
ToppCell	COVID-19-Heart-CM_5_(RYR2-)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NOS1 RYR1	1.86e-03	144	20	2	f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chodl\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	DNAH9 NOS1	1.86e-03	144	20	2	b622b605f7ec6083ec06c8ea0fd171e07c52f3de
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	NOS1 KCNV2	1.89e-03	145	20	2	78f5f4b96420c7f391e4d32a9ed151ed95fad90b
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c4-DNAJB1\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	KCNMA1 RAI2	1.96e-03	148	20	2	e73860f6b8021482f82b83ccd2b7e1dfd7d9e80b
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH8 DNAH7	1.96e-03	148	20	2	6ffa212f0cc44c40d2143816dc6cfd82fbf09a33
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CBR3 RYR1	1.96e-03	148	20	2	d5cace5605bff2bb8248fadb51f2dad7539930ba
ToppCell	LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH9 DNAH7	1.96e-03	148	20	2	d61123f0c811287843d066b932b4a9ff09c07c5b
ToppCell	LPS-antiTNF-Epithelial_airway-Ciliated_cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH9 DNAH7	1.96e-03	148	20	2	c8e93b87212f55774223caa385859c566fa1981f
ToppCell	368C-Fibroblasts-Fibroblast-F-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	DNAH7 PXDNL	1.99e-03	149	20	2	9286bc56ff2e245630537a0bda5f1a1e17be863a
ToppCell	368C-Fibroblasts-Fibroblast-F\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	DNAH7 PXDNL	1.99e-03	149	20	2	f53151d9e5e724a61be0ee6a8c740d1990f28d5f
ToppCell	Serous\|World / shred by cell class for turbinate	KCNMA1 CBR3	2.02e-03	150	20	2	6a326662d58b0f17d6efa8cc28571f4cbbf57c2d
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DNAH8 RYR1	2.02e-03	150	20	2	0205318a870e091add66ee4305747dda9f51510d
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DNAH8 CPT1B	2.02e-03	150	20	2	53de595376a9fc92491dfd58ff25938b0bf79903
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CMAHP NOS1	2.02e-03	150	20	2	cc8361bdcaa16ab6a0d6a3684690d709bc42ff3b
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DNAH8 CPT1B	2.02e-03	150	20	2	e4b40b3243ed26d0c46bf196ac06e148834e7ed2
ToppCell	Ciliated_cells-A-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	DNAH9 DNAH7	2.04e-03	151	20	2	9d03ce73af15ef40c592d19b36aff46bebc14c40
ToppCell	COVID-19-Epithelial_cells-Airway_mucous\|COVID-19 / group, cell type (main and fine annotations)	DNAH9 DNAH7	2.04e-03	151	20	2	8216462e723fec2797387929dde095370947e10a
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CBR3 RYR1	2.07e-03	152	20	2	82a493ffb2f1704cd6f68a82d970fe12f537d20e
ToppCell	URO-Lymphocyte-T_NK-CD4_Naive\|URO / Disease, Lineage and Cell Type	NOS1 LRRN3	2.12e-03	154	20	2	6c214ad5cbbfa8bab3f76b593cb598dfb914b566
ToppCell	Control-Epithelial_airway-Ciliated_cells-Ciliated\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH9 DNAH7	2.12e-03	154	20	2	4e3bc24043144143842627cacf6f90dda2228910
ToppCell	Control-Epithelial_airway-Ciliated_cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH9 DNAH7	2.12e-03	154	20	2	7556a4b2b062da5ae7ec2bbb66e745e7662db628
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH9 DNAH7	2.12e-03	154	20	2	58072ce422d09f2de602580325eaac6c4ec6c136
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells-Ciliated\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH9 DNAH7	2.12e-03	154	20	2	9ca71d440c4f87781e6525b8141e7d8d470b6a8e
ToppCell	ileum-BEST4+_Enterocytes\|ileum / shred on tissue and cell subclass	CMAHP RAI2	2.12e-03	154	20	2	608e9c982125e0c2c15b86b1920813845a0db81f
ToppCell	droplet-Liver-HEPATOCYTES-1m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RHBDL2 CPT1B	2.12e-03	154	20	2	66c93733116e31b65dfb4b0b00de5c39d19cdb84
ToppCell	COVID-19-Heart-CM_5_(RYR2-)\|Heart / Disease (COVID-19 only), tissue and cell type	NOS1 RYR1	2.15e-03	155	20	2	d7e26696fd9c0a759524f331243db43059b33ed9
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH9 DNAH7	2.15e-03	155	20	2	5f1e2195a6b831e1b636f5cc3a282ca423721822
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH9 DNAH7	2.15e-03	155	20	2	0944429459f642a1bcc56edc1ec28aaecde3e2dc
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4-Tregs\|GI_small-bowel / Manually curated celltypes from each tissue	DNAH8 RYR1	2.15e-03	155	20	2	d4ef25965a15eab7679478b9b661e1b4a92f1c59
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CMAHP NOS1	2.18e-03	156	20	2	6f8622716bad4e505f241a2a4ef953bf3fc6dbfa
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Adamts2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CBR3 RYR1	2.18e-03	156	20	2	2cd007b423c2395c5ce331902e7f27c805755eb3
ToppCell	facs-Heart-RA-24m-Mesenchymal-atrial_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RYR3 CPT1B	2.21e-03	157	20	2	9021900d9b1a71210c9c414a9d165eaf399eb607
ToppCell	control-B_cell\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CBR3 RHBDL2	2.21e-03	157	20	2	1269b55f2ef6a493f6116b131cc5cc7b8897d63e
ToppCell	droplet-Liver-HEPATOCYTES-1m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RHBDL2 CPT1B	2.21e-03	157	20	2	b527e88382c8d21188a0f222b3302523e8816dfc
ToppCell	facs-Heart-RA-24m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RYR3 CPT1B	2.21e-03	157	20	2	c8c627ca181856cd31dba4cf073c2be659a49dc1
ToppCell	COVID-19-APC-like-Monocytes\|COVID-19 / group, cell type (main and fine annotations)	LRRN3 RYR1	2.23e-03	158	20	2	a0d94bd067424783863a48db20976d4c2043600c
Computational	Genes in the cancer module 330.	NOS1 RYR1	3.55e-04	28	11	2	MODULE_330
Computational	Muscle genes.	NOS1 RYR1	6.22e-04	37	11	2	MODULE_512
Computational	Genes in the cancer module 387.	NOS1 RYR1	1.09e-03	49	11	2	MODULE_387
Computational	Genes in the cancer module 201.	NOS1 RYR1	1.14e-03	50	11	2	MODULE_201
Computational	Genes in the cancer module 329.	NOS1 RYR1	1.18e-03	51	11	2	MODULE_329
Drug	caged InsP3	KCNMA1 RYR1 RYR3 CPT1B	1.01e-08	29	20	4	CID000122248
Drug	MBED	KCNMA1 RYR1 RYR3	1.16e-08	6	20	3	CID000129958
Drug	5'-adenylyl (beta,gamma-methylene)diphosphonate	RYR1 RYR3	7.33e-07	2	20	2	ctd:C005147
Drug	AC1O3MDH	NOS1 RYR1 GPR182 RYR3	1.74e-06	102	20	4	CID006332158
Drug	S-nitrosoacetylcysteine	KCNMA1 NOS1 RYR1	2.09e-06	29	20	3	CID000122058
Drug	2-hydroxyheptanoic acid	RYR1 RYR3	2.20e-06	3	20	2	CID002750949
Drug	flubendiamide	RYR1 RYR3	2.20e-06	3	20	2	CID011193251
Drug	Ryanodyl 3-(pyridine-3-carboxylate	RYR1 RYR3	2.20e-06	3	20	2	CID005748312
Drug	8N3-cADPR	RYR1 RYR3	2.20e-06	3	20	2	CID000127713
Drug	2-hydroxycarbazole	RYR1 RYR3	2.20e-06	3	20	2	CID000093551
Drug	aminodantrolene	RYR1 RYR3	2.20e-06	3	20	2	CID009570289
Drug	1,1'-diheptyl-4,4'-bipyridinium	RYR1 RYR3	2.20e-06	3	20	2	CID000080262
Drug	cis-diammineplatinum(II	RYR1 RYR3	2.20e-06	3	20	2	CID000159790
Drug	A-30	RYR1 RYR3	4.39e-06	4	20	2	CID003028528
Drug	Bastadin 10	RYR1 RYR3	4.39e-06	4	20	2	CID009589366
Drug	SC 38249	RYR1 RYR3	4.39e-06	4	20	2	CID000134834
Drug	AC1L1U7A	RYR1 RYR3	4.39e-06	4	20	2	CID000035682
Drug	PCB74	RYR1 RYR3	4.39e-06	4	20	2	CID000036218
Drug	148504-47-6	RYR1 RYR3	4.39e-06	4	20	2	CID006444275
Drug	AC1L1IZE	DNAH8 DNAH9 RYR1 RYR3	4.72e-06	131	20	4	CID000004799
Drug	ebselen	KCNMA1 NOS1 RYR1 RYR3	4.72e-06	131	20	4	CID000003194
Drug	CsCl	KCNMA1 RYR1 RHBDL2 RYR3	5.48e-06	136	20	4	CID000024293
Drug	isocitrate	KCNMA1 RYR1 RYR3 CPT1B	9.43e-06	156	20	4	CID000001198
Drug	AC1O528X	RYR1 RYR3	1.10e-05	6	20	2	CID006475857
Drug	NSC114784	RYR1 RYR3	1.10e-05	6	20	2	CID000419425
Drug	NSC692750	RYR1 RYR3	1.10e-05	6	20	2	CID000078910
Drug	chloro-m-cresol	RYR1 RYR3	1.10e-05	6	20	2	CID000012008
Drug	etridiazole	KCNMA1 RYR1 RYR3	1.11e-05	50	20	3	CID000017432
Drug	Nor 3	KCNMA1 NOS1 RYR1	1.11e-05	50	20	3	CID009578441
Drug	AC1L1KRB	RYR1 GPR182 RYR3	1.40e-05	54	20	3	CID000005621
Drug	Azumoleno	RYR1 RYR3	1.54e-05	7	20	2	CID000056259
Drug	mag-indo-1	RYR1 RYR3	1.54e-05	7	20	2	CID000131881
Drug	[[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate	RYR1 RYR3	1.54e-05	7	20	2	CID009547999
Drug	CHEBI:564108	RYR1 RYR3	1.54e-05	7	20	2	CID006400637
Drug	Br2BAPTA	RYR1 RYR3	1.54e-05	7	20	2	CID003081001
Drug	HMS3267E16	RYR1 GPR182 RYR3	2.12e-05	62	20	3	CID000003668
Drug	lactosyl lysosphingolipid	RYR1 RYR3	2.63e-05	9	20	2	CID006439268
Drug	FLA 365	RYR1 RYR3	2.63e-05	9	20	2	CID000072776
Drug	AC1N38XE	RYR1 RYR3	3.28e-05	10	20	2	CID004060965
Drug	PCB 95	RYR1 RYR3	3.28e-05	10	20	2	CID000038012
Drug	R 478	RYR1 RYR3	4.01e-05	11	20	2	CID000084223
Drug	8-amino-cADPR	RYR1 RYR3	4.01e-05	11	20	2	CID003081323
Drug	PCB 66	RYR1 RYR3	4.01e-05	11	20	2	CID000036185
Drug	carbanilide	KCNMA1 RYR1	4.01e-05	11	20	2	CID000007595
Drug	Ryanodine	RYR1 RYR3	4.81e-05	12	20	2	ctd:D012433
Drug	verapamil	KCNMA1 NOS1 KCNV2 RYR1 RYR3	5.37e-05	490	20	5	CID000002520
Drug	NSC299933	RYR1 RYR3	5.68e-05	13	20	2	CID000431902
Drug	cromakalim	KCNMA1 NOS1 CPT1B	6.06e-05	88	20	3	CID000071191
Drug	bimoclomol	RYR1 RYR3	6.63e-05	14	20	2	CID009576891
Drug	CID6426996	KCNMA1 CPT1B	6.63e-05	14	20	2	CID006426996
Drug	NP-EGTA	RYR1 RYR3	6.63e-05	14	20	2	CID000183793
Drug	sodium nitroprusside	KCNMA1 NOS1 RYR1 RYR3	7.08e-05	261	20	4	CID000045469
Drug	FPL 64176	RYR1 RYR3	7.64e-05	15	20	2	CID000003423
Drug	Gvapspat amide	RYR1 RYR3	7.64e-05	15	20	2	CID000125015
Drug	isotetrandrine	KCNMA1 RYR1 RYR3	8.11e-05	97	20	3	CID000005422
Drug	AC1L1KC5	KCNMA1 NOS1 RYR1 GPR182 RYR3	8.58e-05	541	20	5	CID000005428
Drug	indo-1	KCNMA1 RYR1 RYR3	8.62e-05	99	20	3	CID000105060
Drug	rilmakalim	KCNMA1 CPT1B	8.73e-05	16	20	2	CID000065966
Drug	DM-nitrophen	RYR1 RYR3	8.73e-05	16	20	2	CID000003083
Drug	magnesium	KCNMA1 DNAH8 DNAH9 NOS1 RYR1 RYR3 CPT1B	8.81e-05	1325	20	7	CID000000888
Drug	isradipine	KCNMA1 RYR1 RYR3	8.88e-05	100	20	3	CID000003784
Drug	isoflurane	KCNMA1 NOS1 RYR1 RYR3	9.16e-05	279	20	4	CID000003763
Drug	kazinol B	RYR1 RYR3	9.89e-05	17	20	2	CID000480869
Drug	U46619	NOS1 RYR1 GPR182 RYR3	9.94e-05	285	20	4	CID000005618
Drug	sevoflurane	RYR1 RYR3 CPT1B	1.03e-04	105	20	3	CID000005206
Drug	K-Cl	KCNMA1 NOS1 RYR1 RYR3 CPT1B	1.07e-04	567	20	5	CID000004873
Drug	phosphine oxide	KCNMA1 RYR1 RYR3	1.09e-04	107	20	3	CID000166931
Drug	methylcoumarin	RYR1 RYR3	1.11e-04	18	20	2	CID000007092
Drug	guanosine 3',5'-cyclic monophosphoric acid	KCNMA1 DNAH9 NOS1 RYR1 RYR3	1.16e-04	577	20	5	CID000000295
Drug	AC1L380G	RYR1 RYR3	1.24e-04	19	20	2	CID000084698
Drug	AC1MW7VF	RYR1 RYR3	1.24e-04	19	20	2	CID000414699
Drug	SK&F 82958	NOS1 RYR1	1.24e-04	19	20	2	ctd:C071262
Drug	AC1L1IZ2	KCNMA1 DNAH9 RYR1 RYR3	1.28e-04	304	20	4	CID000004795
Drug	AC1L1KF5	NOS1 RYR1 RYR3	1.28e-04	113	20	3	CID000005470
Drug	8-bromoguanosine 3',5'-cyclic monophosphate	KCNMA1 NOS1 RYR1 RYR3	1.34e-04	308	20	4	CID000001915
Drug	halothane	KCNMA1 NOS1 RYR1 RYR3	1.44e-04	314	20	4	CID000003562
Drug	TCNB	TMOD4 RYR1 RYR3	1.49e-04	119	20	3	CID000008330
Drug	indo-1/AM	RYR1 RYR3	1.52e-04	21	20	2	CID000123918
Drug	AC1L1CR9	RYR1 RYR3	1.52e-04	21	20	2	CID000002023
Drug	fluo-3	KCNMA1 RYR1 RYR3	1.60e-04	122	20	3	CID000104978
Drug	BAPTA	KCNMA1 NOS1 RYR1 RYR3	1.63e-04	324	20	4	CID000104751
Drug	Clorocruoro Hem	NOS1 RYR1 RYR3	1.64e-04	123	20	3	CID003518809
Drug	potassium	KCNMA1 NOS1 KCNV2 RYR1 RYR3 CPT1B	1.68e-04	1008	20	6	CID000000813
Drug	AY9944	KCNMA1 GPR182	1.83e-04	23	20	2	CID000009704
Drug	4-phenylimidazole	NOS1 GPR182	2.00e-04	24	20	2	CID000069590
Drug	T0702	RYR1 RYR3	2.17e-04	25	20	2	CID000005908
Drug	lanthanum	CBR3 RYR1 RYR3	2.21e-04	136	20	3	CID000023926
Drug	Kn 04	RYR1 RYR3	2.35e-04	26	20	2	CID000131117
Drug	zaprinast	NOS1 RYR1 RYR3	2.45e-04	141	20	3	CID000005722
Drug	carbachol	KCNMA1 NOS1 RYR1 RYR3 CPT1B	2.64e-04	688	20	5	CID000002551
Drug	Dantrolene-13C3	NOS1 RYR1 RYR3	2.66e-04	145	20	3	CID000002951
Drug	diad	RYR1 RYR3	2.73e-04	28	20	2	CID000075555
Drug	rhod-2	RYR1 RYR3	2.73e-04	28	20	2	CID000123669
Drug	8-dehydrocholesterol	KCNMA1 GPR182	2.73e-04	28	20	2	CID000129846
Drug	peroxynitrite	KCNMA1 NOS1 RYR1 RYR3	2.79e-04	373	20	4	CID000104806
Drug	barium	KCNMA1 NOS1 CPT1B	2.83e-04	148	20	3	CID000104810
Drug	U-37883A	KCNMA1 GPR182	2.93e-04	29	20	2	CID000064392
Drug	2,4-xylidinothiazoline	RYR1 RYR3	3.14e-04	30	20	2	CID000099296
Drug	LOPAC	RYR1 RYR3	3.14e-04	30	20	2	CID000062696
Drug	cobalt-60	KCNMA1 RYR1 RYR3 CPT1B	3.30e-04	390	20	4	CID000061492
Disease	malignant hyperthermia (implicated_via_orthology)	RYR1 RYR3	1.31e-06	3	20	2	DOID:8545 (implicated_via_orthology)
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR1 RYR3	1.31e-06	3	20	2	DOID:3529 (implicated_via_orthology)
Disease	alcohol use disorder (implicated_via_orthology)	KCNMA1 RYR1 RHBDL2 RYR3	8.25e-06	195	20	4	DOID:1574 (implicated_via_orthology)
Disease	pulmonary hypertension (biomarker_via_orthology)	RYR1 GPR182 RYR3	2.12e-05	80	20	3	DOID:6432 (biomarker_via_orthology)
Disease	urate measurement, bone density	KCNMA1 DNAH8 DNAH9 CRBN	7.11e-04	619	20	4	EFO_0003923, EFO_0004531
Disease	Petit mal status	KCNMA1 NOS1	9.40e-04	67	20	2	C0270823
Disease	Status Epilepticus, Subclinical	KCNMA1 NOS1	9.40e-04	67	20	2	C0751522
Disease	Simple Partial Status Epilepticus	KCNMA1 NOS1	9.40e-04	67	20	2	C0751524
Disease	Non-Convulsive Status Epilepticus	KCNMA1 NOS1	9.40e-04	67	20	2	C0751523
Disease	Grand Mal Status Epilepticus	KCNMA1 NOS1	9.40e-04	67	20	2	C0311335
Disease	Complex Partial Status Epilepticus	KCNMA1 NOS1	9.40e-04	67	20	2	C0393734
Disease	Status Epilepticus	KCNMA1 NOS1	9.68e-04	68	20	2	C0038220
Disease	schizophrenia (implicated_via_orthology)	NOS1 LRRN3	9.68e-04	68	20	2	DOID:5419 (implicated_via_orthology)
Disease	amino acid measurement	CMAHP KCNMA1 DNAH7 RYR3	9.98e-04	678	20	4	EFO_0005134
Disease	basophil percentage of granulocytes	CRBN RYR1	1.44e-03	83	20	2	EFO_0007995
Disease	Bell's palsy	KCNMA1 DNAH8	2.16e-03	102	20	2	EFO_0007167
Disease	response to vaccine	DNAH9 CRBN	3.07e-03	122	20	2	EFO_0004645
Disease	Papillary Renal Cell Carcinoma	KCNMA1 RYR1	3.37e-03	128	20	2	C1306837

Protein segments in the cluster

Peptide	Gene	Start	Entry
DSCQVIPVLPQVMMI	CRBN	76	Q96SW2
LCLGESPVVMPIHMQ	RAI2	81	Q9Y5P3
MDALIIPVTMEVPCD	KCNMA1	66	Q12791
LAKPPHLIMRIMDCV	DNAH8	3176	Q96JB1
DIQHKGMNPCPMVLV	NOS1	1271	P29475
RCMHLMLDHIPQVPQ	PXDNL	36	A1KZ92
IMVELPQLTIHQMPC	FUCA2	441	Q9BTY2
IKLVDIQIMCAMGPP	DNAH7	2081	Q8WXX0
MCNELLPIMKPHGRV	CBR3	121	O75828
IIPIPEQSMVQMVCH	DNAH9	2336	Q9NYC9
VEEMCPDIPVLERLM	RYR1	3236	P21817
EEIKPVMALGIVPMC	CPT1B	291	Q92523
CMQLVLGIPLEMVHK	RHBDL2	141	Q9NX52
HFRDMMEICLPLIAP	LRRN3	411	Q9H3W5
HIQLVEGPEPMCLFM	GPR182	191	O15218
PDLRPILEHVEMLCM	KCNV2	296	Q8TDN2
ILMDGVHPEMDTCII	CMAHP	156	Q9Y471
EMPHVIEVILPMLCN	RYR3	3126	Q15413
QDIPIPMLSELCEAM	TMOD4	206	Q9NZQ9
QELMEMCHKPEVELL	TRIM43B	231	A6NCK2